Dr. Michael Reihart, with Penn State Health, also explained who's most at risk for severe illness and how effective this year's vaccine is.
While Ontario is seeing a busy flu season this year, some parts of the U.S. have been reporting the highest number of flu ...
Moderna is now expecting 2025 research and development costs of about $4.1 billion and selling, general and administrative costs of about $1.1 billion. Cost of sales is expected to come to about $1.2 ...
The Canadian Press on MSN1h
Flu cases continue to rise across Canada, public health agency data showFlu cases are continuing to rise across the country, public health data show, with Quebec, B.C. and the territories ...
Here are four more respiratory illness updates: Nearly 1.7% of all deaths nationwide were attributed to flu, compared to approximately 1.5% from COVID-19. Influenza test positivity rose to 31.6%, ...
Inhalon’s inhaled antibody therapy aims to address this need, the release said. Its RSV candidate is part of a more broad effort to develop therapies that deliver therapeutic antibodies directly to ...
Dr. Smith is the president of the Tennessee Chapter of the American Academy of Pediatrics.
The U.S. has seen earlier and more intense surges of the flu and RSV this year than is typical, pediatrician Dr. Ryan Fulton ...
MRNA's competitive landscape, particularly against Pfizer, and higher forward P/S ratio suggest the stock is overvalued and ...
Babies under 8 months old are eligible to get an RSV vaccine, and women who are pregnant can also get it to protect kids before they're born. The vaccine is available now through March. If you have ...
We recently published a list of 7 Best Nanotech Penny Stocks to Invest In. In this article, we are going to take a look at ...
As viral illness rates soar across Mississippi and the nation, a University of Mississippi health expert is urging the public to take proactive steps to protect their health.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results